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ABSTRACT cDNA encoding a receptor-like protein-
tyrosine-phosphatase (PTP) termed DEP-1 was isolated from a
HeLa cell library. The cDNA predicts an enzyme consisting of
an extracellular segment containing eight fibronectin type III
repeats, a single transmembrane segment, and a single intra-
cellular PTP domain. Following expression of DEP-1 cDNA in
COS cells a glycoprotein of 180 kDa was detected and PTP
activity was demonstrated in complexes with a C-ter-
minal peptide antiserum. Endogenous DEP-1 was detected in
WI-38 'human embryonic lung fibroblasts by immunoblotting
and immuwcomplex PTP assays. Immunoblot analysis of
DEP-1 expression in WI-38 cells revealed dramtically in-
creased levels and activity of the PTP in dense culture relative
to sparse cultures. Also, DEP-1 activity, detected in'PTP assays
of immunocomplexes, was increased in dense cell cultures. In
contrast, the expression levels of PTP-1B did not change with
cell density. This enement of DEP-1 expression with
increasing cell density was also observed in another fibroblast
cell line, AG1518. The increase in DEP-1 occurs gradually with
increasing cell contact and is initiated before saturation cell
density is reached. These observations suggest that DEP-1 may
contribute to the mec of contact inhibition of cell
growth.
Protein tyrosine phosphorylation is an essential element of
signal transduction pathways that control fundamental cel-
lular processes, including growth and differentiation, the cell
cycle, and cytoskeletal function (1). The phosphorylation
state of tyrosine residues in a target substrate is governed by
the coordinated action of both protein-tyrosine kinases
(PTKs) and protein-tyrosine-phosphatases (PTPs). Like the
PTKs, the PTPs represent a large and diverse family of
enzymes found ubiquitously in eukaryotes (2). Each PTP
contains at least one conserved domain of =240 aa that is
characterized by the signature motif (I/V)HCXAGXGR(S/
T)G. The structural diversity within the PTP family arises
primarily from the variety of putative regulatory sequences
linked to the catalytic domains.
Cytoplasmic PTPs possess a single catalytic domain flanked
at either the N or the C terminus by regulatory sequences that
include Src homology 2 domains, segments ofhomology to the
cytoskeleton-associated protein band 4.1 or to lipid-binding
proteins, and motifs that direct association with intracellular
membranes. These structural features implicate subcellular
compartmentalization in the control of catalytic function (re-
viewed in refs. 3 and 4). In addition, analogous to the PTKs,
receptor-like PTPs have been identified, suggesting the po-
tential for control of signal transduction events through ligand-
modulated dephosphorylation of tyrosine residues in proteins.
Generally the structure ofreceptor-like PTPs can be described
in terms of an intracellular segment containing one or two
phosphatase domains, a single transmembrane domain, and a
variable extracellular segment. These receptor-like PTPs can
be distinguished on the basis of the diversity of their extra-
cellular segments, which presumably reflects an equivalent
diversity in the variety of ligands to which they may respond
(3). However, a common structural theme among receptor
PTPs is the presence of motifs found in proteins involved in
cell adhesion. Thus the extracellular segment of PTP, (5) and
SAP-i (6) in humans and DPTP1OD and -99A (7-9) and
DPTP4E (10) in Drosophila are characterized by a repeated
array of fibronectin type III (FNIII) motifs, while LAR (11),
PTP~u (12), and PTPK (13), among others, possess multiple
FNIII motifs in combination with immunoglobulin (Ig)-like
domains. Such an arrangement of FNIII and Ig-like motifs is
also found in members of the Ig superfamily of cell adhesion
molecules that includes neural cell adhesion molecule
(NCAM) (14). As may be anticipated from the similarity to
NCAM, it has been demonstrated that PTPtt can promote
cell-cell aggregation through homophilic binding interactions;
i.e., the ligand for PTPjL is another molecule of the same
enzyme expressed on the surface of an apposing cell (15, 16).
Similar observations have now also been made for PTPK (17).
Such data reinforce the concept that receptor PTPs may
play a role in transducing signals initiated by cell-cell contact.
For example, normal cells display density-dependent arrest of
cell growth (18). Thus, as cultures approach confluence and
adjacent cells touch each other, growth is inhibited. Since
tyrosine phosphorylation triggered by growth factor receptor
PTKs has been implicated in promoting cell growth and
proliferation (1), PTPs, as the natural antagonists of PTK
function, may exert a negative effect on such growth-
promoting signals. We report the isolation ofcDNA encoding
a receptor-like PTP whose expression may contribute to the
contact inhibition of cell growth. It comprises eight FNIII
repeats in its extracellular segment, a single transmembrane
domain, and a single intracellular catalytic domain. Intrinsic
activity has been demonstrated. The most striking property of
this enzyme is that in two distinct cells lines expression is
enhanced .10-fold as cells approach confluence. We propose
the name DEP-1 (high cell density-enhanced PTP 1) for this
enzyme.§
MATERIALS AND METHODS
Isolation and Characterization of DEP-1 cDNA. Primers
corresponding to amino acid sequences KCAQYWP and
HCSAGIG from the conserved PTP domain were used in a
polymerase chain reaction (PCR) with phage DNA of a HeLa
cell cDNA library as template. A =300-bp PCR fragment was
identified and used to screen a HeLa cell cDNA library
Abbreviations: FNIII, fibronectin type III; NCAM, neural cell
adhesion molecule; PTK, protein-tyrosine kinase; PTP, protein-
tyrosine-phosphatase.
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(Stratagene). Of 1.8 x 106 phage plaques screened (19), 24
positive clones were identified. The largest, a 5.1-kb cDNA,
was cloned and sequenced by the dideoxy chain-termination
method. The open reading frame was sequenced on both
strands.
Cell Culture and Transfections. WI-38 human embryonic
lung fibroblasts and COS transformed monkey kidney fibro-
blasts (ATCC) and AG1518 foreskin fibroblasts (Human
Mutant Cell Repository, Camden, NJ) were grown in Dul-
becco's modified Eagle's medium and Eagle's medium, re-
spectively, containing 10%1 fetal bovine serum and supple-
mented with antibiotics. COS cells were transfected by a
standard calcium phosphate method, with lysates prepared
48 hr after transfection.
Antibodies to DEP-1 and Immunoblotting and Immunocom
plex Assays. Two peptides, corresponding to aa 1297-1315
(peptide CSH-241) and 1321-1334 (CSH-243) at the C terlinus
of DEP-1, were synthesized and coupled to rabbit serum
albumin and polyclonal antisera were generated in rabbits by
standard procedures. Cells were lysed in 20 mM Hepes, pH
7.5/0.5% sodium deoxycholate/0.5% Triton X-100/150 mM
NaCl/1 mM benzamidine/1 mM dithiothreitol with aprotinin
(5 yg/ml) and leupeptin (5 pg/ml). For immunoblotting, after
semidry electrophoretic transfer to nitrocellulose, filters were
blocked and then probed with affinity-purified anti-DEP-1
(CSH-243) antibody or with anti-PTPlB monoclonal antibody
FG6. Immunoreactive species were detected by enhanced
chemiluminescence (ECL; Amersham). For immunocomplex
PTP assays, 60 .g of cell lysate was immunoprecipitated with
20 A1 of anti-DEP-1 (CSH-243) antiserum (with or without
pretreatment with antigen), preimmune serum, or 4 pg of
anti-PTP1B monoclonal antibody FG6. Washed immunocom-
plexes were assayed for PTP activity in triplicate with 3 AM
[32P]phosphotyrosine-containing reduced, carboxamidometh-
ylated, and maleylated lysozyme as substrate (20). Measure-
ments of total PTP activity used 1-2 pg of cell lysate protein
per assay. Protein concentration was determined by the
method of Bradford (21).
RESULTS
Isolatin and Characterization of DEP-1 cDNA. A fragment
encoding a segment of the catalytic domain of a putative PTP
was identified by PCR amplification of phage DNA from a
HeLa cell cDNA library. This PCR fragment was used to
screen a HeLa cell cDNA library. A phage clone containing a
5.1-kb insert with an open reading frame of 4011 nt encoding
a receptor-like PTP of 1337 aa was isolated (Fig. 1A). The
proposed initiatingATG codon is flanked by a purine (G) at the
-3 position and is thus in agreement with the Kozak rules for
initiation (22). There is an in-frame stop codon -290 bp
upstream of the predicted initiation site. The initiating methi-
onine is followed by a hydrophobic sequence that may serve
as a signal sequence. Based on the statistical analysis ofknown
cleavage sites for the signal peptidase (23), the mature N
terminus has been assigned to Gly37. A second hydrophobic
region is found between aa 977 and 996 and is followed by a
series ofpredominantly basic residues, a feature characteristic
of a stop-transfer sequence. Thus, a putative mature extra-
cellular segment of 940 aa and an intracellular portion of 341
aa are predicted by the cDNA sequence (Fig. 1). The extra-
cellular portion is largely composed of eight FNIII domains,
whereas the intracellular segment contains a single PTP do-
main spanning aa 1060-1296 (Fig. 1). Thirty-four potential
sites for N-linked glycosylation were identified in the extra-
cellular segment. Sequence comparisons of the catalytic do-
main of DEP-1 with other PTPs revealed that the closest
relationships are to PTP3 (5) and SAP-i (6) (55% and 46%
identity in the catalytic domains, respectively).
Transient Expression of DEP-1 in COS Cells. To study the
protein product of the DEP-1 cDNA, the 5.1-kb EcoRI insert
was cloned into the expression vector pMT2 (41) and the
construct was transfected into COS cells. Affinity-purified
anti-CSH-243 antibodies, raised against a C-terminal peptide
of DEP-1, detected a protein of -180 kDa in lysates of
DEP-1-transfected cells. This protein was not detected when
antibodies had been preincubated with the peptide conjugate
used for immunization (Fig. 2A). Treatment of transfected
cells with tunicamycin reduced the apparent size of the
DEP-1 immunoreactive species to 140 kDa, indicating that
the 180-kDa form is glycosylated. Furthermore when immu-
nocomplexes were assayed for PTP activity, -10-fold higher
activity was detected in anti-CSH-243 immunocomplexes
from the transfected cells than in the immunocpmplexes from
the untransfected cells (Fig. 2B). Most of this activity was
absent in immunocomplexes derived from immunoprecipita-
tions using antiserum preincubated with the peptide conju-
gate or preimmune serum. Thus, DEP-1 cDNA encodes a
180-kDa glycoprotein with intrinsic PTP activity.
Cell Density-Dependent Expression of E us DEP-1 in
WI-38 and AG1518 Cells. Northern and immunoblot analyses
indicate that DEP-1 is broadly expressed (data not shown).
Of those cell lines tested, WI-38 cells, a diploid fetal lung
fibroblast-like cell line with finite lifespan, showed the high-
est level of protein expression (data not shown). DEP-1 was
recovered from a membrane-enqched fraction of lysates of
WI-38 cells as a protein of 180 a recognized specifically
by the anti-peptide antiserum (data not shown).
There have been reports of increased PTP activity in
lysates of cells from dense relative to sparse cell cultures
(24). Therefore WI-38 cell lysates from sparse (<7000 cells
per cm2) or dense (>25,000 cells per cm2) cultures were
compared by immunoblotting for their content of DEP-1.
DEP-1 expression was at least 10-fold higher in the dense
cell cultures (Fig. 3A). Similar results were obtained with a
second anti-peptide antiserum against DEP-1 (data not
shown). These effects on DEP-1 expression were not re-
stricted to WI-38 cells. Similar results were obtained in the
human foreskin fibroblast cell line AG1518 (Fig. 3A). When
the amount of PTP1B, a ubiquitously expressed cytoplas-
mic enzyme that is the major PTP in many tissues and cell
lines, was compared in sparse and dense cells, no difference
was observed (Fig. 3B). DEP-1 and PTP1B immunocom-
plexes, as well as total cell lysates, from sparse and dense
cell cultures were also analyzed in PTP assays (Fig. 3C). In
agreement with the findings from the immunoblotting ex-
periments, DEP-1 activity was increased in the dense cell
cultures. The observed increase in activity in DEP-1 im-
munoprecipitates was not as great as the increase observed
by comparative immunoblotting of lysates of sparse and
dense cell cultures, because we were unable to precipitate
all of the DEP-1 with this antibody. No difference was
observed in activity of PTP1B in immunoprecipitates or in
total PTP activity in cell lysates from sparse and dense cell
cultures (Fig. 3C).
Finally, to investigate the kinetics ofthe density-dependent
up-regulation of DEP-1 expression, lysates of cells at inter-
mediate cell densities were included in the analysis. The
highest expression was found in cells at saturation density,
but at intermediate densities an increase in expression rela-
tive to sparse cell cultures was also observed (Fig. 4). Thus,
the up-regulation of DEP-1 is initiated before saturation
density is reached and is therefore not solely a consequence
of growth arrest.
DISCUSSION
Unlike most receptor PTPs, which possess a tandem repeat
of two catalytic domains, DEP-1 contains only one PTP
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FIG. 1. Nucleotide and predicted amino acid sequence ofDEP-1. Shading defines the conserved catalytic domain that is homologous to other
members ofthe PTP family. The putative signal and transmembrane sequences are underlined in bold. A segment of each predicted PNI1 motif
is presented as the intervening sequence between the invariant tryptophan and tyrosine residues found toward the N and C termini, respectively,
of the hydrophobic core of the domain underlined. Potential asparagine (N) glycosylation sites are in bold type.
domain in its intracellular segment. It therefore joins an nization of their extracellular segments, which comprise a
expanding groupof such receptors that includes PTPB (5) and repeated array of multiple FNIII motifs. These would be
SAP-i (6) from humans and DPTP1OD (8,9) and DPTP4E (10) expected to form a rod-like structure projecting from the
from Drosophila. These enzymes also share a similar orga- surface of the cell (25).
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FIG. 2. Transient expression of DEP-1. COS cells were mock-
transfected or transfected with pMT2-DEP-1 and treated with tuni-
camycin (0.2 ,g/ml) or left untreated (A). Ten micrograms of cell
lysate protein was analyzed by immunoblotting using affinity-
purified anti-CSH-243 antibodies (Abs) in the absence (unblocked) or
presence (blocked) of competing antigen. (B) For immunocomplex
PTP assays, 60 ,ug of COS cell lysate was immunoprecipitated with
preimmune serum (cross-hatched bars) or anti-CSH-243 antiserum in
the absence (solid bars) or presence (stippled bars) of competing
antigen. These data are representative of three such experiments.
FNIII motifs were originally described in the extracellular
matrix protein fibronectin and comprise =90 residues (26).
The three-dimensional structure of two such domains has
been determined and shown to fold with a topology similar to
that of Ig domains (25, 27). It consists of seven (3-strands
forming a sandwich of two antiparallel (-sheets-one with
three strands and the other with four. Comparison of the
sequences of FNIII motifs illustrates several highly con-
served residues, in particular hydrophobic residues, such as
the invariant tryptophan and tyrosine (residues 22 and 68
respectively in the 10th FNIII motif of fibronectin) that lie at
the N- and C-terminal ends of the core. In addition, there is
a highly conserved loop linking (3-strands E and F which has
a consensus sequence GLXPG (25, 27). While these features
are conserved in the predicted FNIII motifs of DEP-1, the
sequence conservation following the invariant tyrosine,
equivalent to residue 68 in the F strand of the 10th FNIII
motif of fibronectin, is less pronounced. The greatest varia-
tion would be in the G strand, which contributes to the
116-
2 /7 / \ \
cells x 10-3cm 4 10 16 40
FIG. 4. Analysis of DEP-1 expression at various cell densities.
WI-38 cells were harvested at the indicated cell densities and lysates
(10 gg) were analyzed by immunoblotting with affinity-purified
anti-CSH-243 antibodies. Photomicrographs of cell cultures at the
various cell densities are shown below.
four-stranded sheet. While secondary-structure predictions
suggest that some of the sequences following the invariant
tyrosine residue of the predicted FNIII motifs of DEP-1 may
form j3-strands, the precise nature of the fold in these cases
remains unclear. Nevertheless, with the exception of the
third FNIII motif, there are sufficient residues to allow for
domains of -85 residues.
FNIII motifs have been detected in >50 different eukary-
otic proteins, both extracellular and intracellular, and have
even been observed in prokaryotes (28). Most of these
domains have no established function. However in fibronec-
tin itself, which contains 15-17 such motifs, some roles have
been ascribed (26). The best characterized interaction with
fibronectin involves FNIII motif 10, which is the major site
for cell adhesion. FNIII motif 10 contains the cell attach-
ment-promoting sequence RGD, which promotes adhesion
by binding to members of the integrin superfamily, a process
that is augmented by interactions between heparin binding
sites in fibronectin and cell surface proteoglycans. Although
none of the FNIII motifs in DEP-1 contains an RGD se-
quence, which would normally be located on the loop be-
tween the F andG strands (25, 27), anXGD sequence is found
on the expected loop in five of these motifs. It is possible that
the extracellular segment of this PTP may participate in
cell:cell interactions as a heterophilic adhesion molecule.
Great progress has been made in defining the mitogenic
signaling pathways initiated by the binding of growth factors
to their cognate receptor PTKs or triggered by the aberrant
activation of oncogenic PTKs (29, 30). In contrast, the
precise mechanisms underlying the inhibition of cell growth
that occurs as normal cells approach confluence remain to be
ascertained. The involvement of surface glycoproteins such
as NCAM (31) and contactinhibin (32) has been proposed but
their precise role is unclear. In light of the reversibility of
tyrosine phosphorylation in vivo, the PTPs may function as
natural antagonists ofPTK action to keep the kinase activity
in check and prevent uncontrolled growth and proliferation.
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FIG. 3. Comparison of expression of DEP-1 and PTP1B in sparse and dense cells. (A) Indicated amounts of WI-38 (Left and Center) or
AG1518 (Right) cell lysates from sparse or dense cultures were analyzed by immunoblotting with affinity-purified anti-CSH-243 antibodies in
the absence (Left and Right) or presence (Center) of competing antigen. (B) Five micrograms of WI-38 cell lysates was analyzed by
immunoblotting with the anti-PTP1B monoclonal antibody FG6. (C) Immunocomplex PTP assays of DEP-1 and PTP1B and total activity in cell
lysates from sparse and dense cultures presented as mean SEM for 12 (DEP-1), 7 (PTP1B), and 8 (total cell lysate) determinations.
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In fact, the specific activity of PTPs measured in vitro, as
illustrated originally for PTP1B (33) and subsequently for
many other members ofthe family, is 1-3 orders ofmagnitude
in excess of that of the PTKs. This implies that the PTPs may
exert a dominant influence on PTKs in vivo. The ability of a
receptor PTP to counteract the growth-stimulatory potential
of receptor PTKs was illustrated by expression of CD45 in
murine C127 cells, which led to a 70%6 decrease in the
mitogenesis induced by platelet-derived growth factor and
insulin-like growth factor I (34). This inhibition correlated
with a decrease in phosphotyrosine in a subset of proteins,
including the receptor PTKs themselves, whose phosphory-
lation on tyrosine residues was induced by growth factor
binding. Similarly overexpression of PTP1B antagonizes the
oncogenic potential of v-Src (35) and Neu (36). Furthermore,
mutations in the gene for HCP, a Src homology 2 domain-
containing PTP, cause the severe immune dysfunction char-
acteristic of the motheaten phenotype in mice (37). Under
normal conditions HCP may act as a suppressor of PTK
signaling pathways-e.g., the receptor for colony-stimulating
factor 1.
PTPs have been directly linked to density-dependent arrest
of cell growth. Treatment of NRK cells with vanadate, a
potent inhibitor of PTPs, was able to overcome density-
dependent growth inhibition and stimulate anchorage-
independent proliferation, a hallmark of transformed cells
(38, 39). This generation of a transformed morphology was
accompanied by increased cellular phosphotyrosine (38).
Based on data such as these, it has been suggested that some
PTPs may be the products of tumor-suppressor genes-i.e.,
their deletion or mutation may contribute to the increase in
phosphotyrosine that is associated with certain neoplasias.
Mutations observed in the gene for RPTPy in murine L cells
would be consistent with this hypothesis (40). In 3T3 cells the
activity of a PTP in the membrane fraction is enhanced 8-fold
in cells harvested at high density compared with low- or
medium-density cultures (24). This increase was not seen in
subconfluent cultures brought to arrest by serum deprivation.
No information was presented to indicate the identity of the
PTP involved in this effect and whether the elevated activity
was the result of changes in specific activity or expression
levels. However its apparent size on gel filtration, 37 kDa,
suggests that it may be derived from a larger enzyme by
proteolysis.
In this paper we describe a receptor-like PTP, DEP-1,
whose expression is induced in two distinct lines as cells
approach confluence and come into contact with each other.
Thus the enhanced expression of the phosphatase, possibly
coupled with fine tuning of the activity through ligand binding
to the extracellular segment, could be envisaged as promoting
net dephosphorylation of proteins in the membrane, thus
countering the effects of the growth-promoting PTKs. The
mechanism by which this induction of DEP-1 expression is
achieved remains unclear. However, the broad distribution
of DEP-1 suggests that it may be involved in a general
mechanism of contact inhibition of cell growth.
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